Ceylinco Holdings Income Statement

Financials in millions LKR. Fiscal year is January - December.

Millions LKR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Premiums & Annuity Revenue	61,789	58,197	51,476	47,380	43,475	38,584
Total Interest & Dividend Income	31,042	31,259	30,671	32,965	27,160	16,234
Gain (Loss) on Sale of Investments	-110.22	-110.22	305.39	201.48	44.99	301.7
Non-Insurance Activities Revenue	7,786	7,593	6,417	5,625	4,344	3,852
Other Revenue	1,879	1,879	2,164	1,757	1,658	1,254
Total Revenue	102,385	98,818	91,033	87,929	76,682	60,225
Revenue Growth (YoY)	11.00%	8.55%	3.53%	14.67%	27.32%	8.12%
Policy Benefits	63,078	60,477	56,143	54,453	40,215	31,699
Policy Acquisition & Underwriting Costs	6,079	5,807	5,105	4,930	4,557	4,452
Selling, General & Administrative	17,105	16,803	14,413	12,354	12,571	12,032
Non-Insurance Activities Expense	1,853	1,780	1,574	1,577	1,167	862.54
Total Operating Expenses	88,115	84,867	77,235	73,315	58,510	49,045
Operating Income	14,270	13,951	13,799	14,614	18,172	11,180
Interest Expense	-319.5	-290.18	-278.48	-274.49	-265.91	-150.39
Earnings From Equity Investments	926.8	1,150	1,282	568.55	943.01	1,305
Other Non Operating Income (Expenses)	-164.56	-164.56	-133.2	-117.74	-124.01	-99.15
EBT Excluding Unusual Items	14,713	14,647	14,669	14,791	18,725	12,235
Gain (Loss) on Sale of Assets	174.37	174.37	74.02	55.93	28.94	16.56
Asset Writedown	628.73	628.73	100.02	115.49	-2,473	371.36
Pretax Income	15,516	15,450	14,843	14,962	16,281	12,623
Income Tax Expense	4,051	3,925	4,539	3,434	3,025	2,563
Earnings From Continuing Ops.	11,464	11,524	10,304	11,528	13,256	10,061
Minority Interest in Earnings	-1,122	-1,076	-834.68	-733.51	-612.62	-325.1
Net Income	10,342	10,448	9,470	10,795	12,643	9,736
Net Income to Common	10,342	10,448	9,470	10,795	12,643	9,736
Net Income Growth	16.78%	10.33%	-12.27%	-14.62%	29.87%	4.95%
Shares Outstanding (Basic)	26	26	26	26	26	26
Shares Outstanding (Diluted)	26	26	26	26	26	26
EPS (Basic)	391.54	395.56	358.51	408.67	478.66	368.58
EPS (Diluted)	391.54	395.56	358.51	408.67	478.66	368.58
EPS Growth	16.78%	10.33%	-12.27%	-14.62%	29.87%	4.95%
Free Cash Flow	30,731	33,847	30,912	21,596	16,298	19,776
Free Cash Flow Per Share	1163.43	1281.40	1170.27	817.58	617.03	748.69
Dividend Per Share	51.000	51.000	51.000	48.000	45.000	42.000
Dividend Growth	-	-	6.25%	6.67%	7.14%	5.00%
Operating Margin	13.94%	14.12%	15.16%	16.62%	23.70%	18.56%
Profit Margin	10.10%	10.57%	10.40%	12.28%	16.49%	16.16%
Free Cash Flow Margin	30.01%	34.25%	33.96%	24.56%	21.25%	32.84%
EBITDA	15,136	14,850	14,828	15,711	19,100	12,063
EBITDA Margin	14.78%	15.03%	16.29%	17.87%	24.91%	20.03%
D&A For EBITDA	866.26	898.93	1,030	1,096	927.94	882.34
EBIT	14,270	13,951	13,799	14,614	18,172	11,180
EBIT Margin	13.94%	14.12%	15.16%	16.62%	23.70%	18.56%
Effective Tax Rate	26.11%	25.41%	30.58%	22.95%	18.58%	20.30%
Revenue as Reported	103,188	99,621	91,208	88,114	77,020	60,613

Source: S&P Global Market Intelligence. Insurance template. Financial Sources.